NCT04914026View on ClinicalTrials.gov

MicroRNA as Markers in Testicular Cancer

RecruitingOBSERVATIONAL
Enrollment

350

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Testicular Germ Cell CancerSeminomaNon-Seminoma Testicular CancerStage I Testicular CancerStage II Testicular CancerStage III Testicular CancerStage IV Testicular CancerRelapse Testicular Cancer
Interventions
OTHER

Biomarker analysis

Blood collection. Blood samples will be collected at diagnosis, during surveillance, during treatment and every 3-6 months

Trial Locations (6)

5021

RECRUITING

Haukeland University Hospital, Bergen

5528

RECRUITING

Haugesund Hospital, Haugesund

9038

RECRUITING

University Hospital of North Norway, Tromsø

41345

NOT_YET_RECRUITING

Sahlgrenska University Hospital, Gothenburg

0379

NOT_YET_RECRUITING

Oslo University Hospital, Oslo

Unknown

RECRUITING

Karolinska University Hospital, Stockholm

All Listed Sponsors
collaborator

Karolinska University Hospital

OTHER

collaborator

Sahlgrenska University Hospital

OTHER

collaborator

Helse Fonna

OTHER

collaborator

University Hospital of North Norway

OTHER

collaborator

Oslo University Hospital

OTHER

lead

Haukeland University Hospital

OTHER

NCT04914026 - MicroRNA as Markers in Testicular Cancer | Biotech Hunter | Biotech Hunter